Policy
Funding, regulation, coverage, and care systems.
Governor Kathy Hochul has signed a law forcing New York's long-term care hotline, NY Connects, to actively point callers toward Alzheimer's and dementia programs rather than leaving them to ask. The catch: nothing changes for a full year.
The National Institute for Health and Care Research has extended its Policy Research Unit at the University of Exeter with 2 million pounds and two extra years, stretching its mandate past dementia and neurodegeneration to cover more of the neurological conditions families live with.
Governor Wes Moore has signed a law replacing Maryland's lone dementia director with a full state program, and ordered health officials to find out whether the state's clinicians are actually ready for the patients already walking into their offices.
H.R.6130 would give Medicare, for the first time, legal authority to cover blood-based screening for Alzheimer's disease and related dementias. The bill sets January 1, 2028 as the earliest possible start date, a date that holds only if the measure becomes law.
A regional midterm review of the UN Decade of Healthy Aging finds that the share of countries in the Americas with a national long-term-care policy jumped from 61 percent to 88 percent since 2020, but the money and services to make those policies real have not kept pace, with direct consequences for how dementia care gets funded and staffed.
UK Research and Innovation has launched the Dementia Challenge, funding real-world NHS trials of faster MRI scans, blood tests and remote cognitive assessments, with a target of diagnosing 92% of referred patients within 18 weeks, up from about 60% today.
The regulator's own project page now shows the formal evaluation on hold while the manufacturer and the health service negotiate directly, after appeal panels forced it to reopen contested carer-cost and infusion-pricing evidence.
H.R. 3747 would add dementia care to the list of specialty topics eligible for federal Project ECHO training grants and reauthorize the program through 2031, but it has not become law.
The Credit for Caring Act, reintroduced in the House and Senate in March 2025, would create a new federal tax credit of up to $5,000 for working family caregivers. More than a year later, the bipartisan bill remains in committee with no vote scheduled.
A peer-reviewed report on the second Healthy Brain Initiative Summit for Public Health Action describes state and local officials from 43 jurisdictions converging on shared dementia priorities, while naming continued federal funding as essential to keeping the effort moving.
Since July 1, 2026, residents of dedicated memory care units can no longer join the GUIDE Model, assisted living residents have lost access to its respite benefit, and providers must get CMS approval before signing new partnerships with residential care communities.
A peer reviewed account by FDA staff describes 2025 label changes that let three approved brain scans be used specifically to select patients for amyloid clearing therapies, and that allow a numerical plaque reading alongside the standard visual read.
A peer-reviewed legal mapping study published in July 2026 compared assisted living regulations in ten states against the Alzheimer's Association's care recommendations. The paperwork looked nothing alike, and no one agency was checking.
In a peer-reviewed update, the World Dementia Council says regulators have approved the first disease-modifying Alzheimer's treatments while payers keep saying no, and asks why that gap has produced so little public fury.
The OECD's new stocktake of national dementia policy catalogues strategies in 38 member countries and finds most of them have one. What it cannot find, in most cases, is the money and the monitoring that would turn the document into a service a family can actually reach.
The World Health Organization has released an executive summary distilling its second edition of dementia risk reduction guidelines for governments, replacing the reference document that has anchored national dementia plans since 2019.
The Department of Health and Human Services has published a formal timeline and process for replacing the current National Plan to Address Alzheimer's Disease, including a public comment period and Advisory Council review, with a new version targeted for late 2026.
A full-year spending bill signed into law in February makes concrete a funding increase that had been advancing through Congress since mid-2025, splitting new money between two NIH institutes that lead the government's dementia research portfolio.
Two years after the GUIDE Model began paying for comprehensive dementia care, and one year after its larger wave of programs went live, geriatricians publish a four-step blueprint drawn from six earlier care programs. It is a plan for building services, not evidence that they work.
A peer-reviewed commentary in Frontiers in Dementia traces a quiet chokepoint in American long-term care: to reach Medicaid home care through the disability route, you generally need a disability determination, and to get that you generally need a formal dementia diagnosis. Fewer than half of people living with dementia have one.
The government has promised a Modern Service Framework for Frailty and Dementia. Ministers have confirmed an interim product in September 2026 and the full framework by the end of the year, after a spring expectation quietly gave way and Baroness Casey pressed for speed.
A peer-reviewed protocol sets out how researchers will measure home and community service use among 46,053 post-9/11 veterans aged 65 or younger with frontotemporal dementia, early-onset Alzheimer's, or elevated risk after brain injury. No results yet.
Dutch researchers asked 28 relatives in GRN, MAPT and C9orf72 families why they would, or would not, learn their genetic status. Alongside fear of the result sat something more mundane: insurance forms, mortgage applications and work. Published in Human Genetics on 16 February 2026, the study reads less like a counselling problem than a policy one.
The Australian Commission on Safety and Quality in Health Care released an updated Stroke Clinical Care Standard on 11 June 2026, dropping the word "acute" from the title and telling teams to reassess mood and cognition throughout admission and before discharge.
The Five-Star Technical Users' Guide says that from the April 2026 refresh every long-stay resident with a history of schizophrenia is dropped from the publicly reported antipsychotic measure, weeks after a federal watchdog said the diagnosis had been used to hide prescribing.
An HHS inspector general audit of registered nurse hours for a single month found that 45 of 100 sampled items were not supported by records, and projected about 938,000 unsupported hours nationally, six months after the federal staffing minimum for nursing homes was repealed.
A USC-led microsimulation published in Alzheimer's & Dementia counts unpaid care, lost earnings and lost quality of life alongside medical bills. The Alzheimer's Association's narrower measure for the same year is $409bn.
The Federal Register notice of 24 July asks the public what the plan's goals should be through 2035. It does not mention the performance targets the Government Accountability Office said were missing, and comments close on 15 August.